Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Mar;47(3):357-358.
doi: 10.1007/s00134-020-06335-5. Epub 2021 Jan 28.

The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19. Author's reply

Affiliations
Comment

The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19. Author's reply

G Umberto Meduri et al. Intensive Care Med. 2021 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no financial or personal relationships with other people or organizations that could inappropriately influence (bias) their work.

Comment on

References

    1. Anon JM, Villar J. Ten reasons why corticosteroid therapy reduces mortality in severe COVID-19. Intensive Care Med. 10.1007/s00134-020-06330-w - PMC - PubMed
    1. Meduri GU, Annane D, Confalonieri M, Chrousos GP, Rochwerg B, Busby A, Ruaro B, Meibohm B. Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS. Intensive Care Med. 2020;46:2284–2296. doi: 10.1007/s00134-020-06289-8. - DOI - PMC - PubMed
    1. Villar J, Ferrando C, Martinez D, Ambros A, Munoz T, Soler JA, Aguilar G, Alba F, Gonzalez-Higueras E, Conesa LA, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respirat Med. 2020;8(3):267–276. doi: 10.1016/S2213-2600(19)30417-5. - DOI - PubMed
    1. Horby P, Lim WS, Emberson J, Mafham M, Bell J, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E (2020) Dexamethasone in hospitalized patients with Covid-19—preliminary report. N Engl J Med. 10.1056/NEJMoa2021436 - PubMed
    1. Salton F, Confalonieri P, Meduri GU, Santus P, Harari S, Scala R, Lanini S, Vertui V, Oggionni T, Caminati A (2020) Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia. In: open forum infectious diseases: Oxford University press US, vol 7, ofaa421 - PMC - PubMed

Substances

LinkOut - more resources